Robert F. Williamson III, Director at Perspective Therapeutics, Inc. (CATX), bought 135,879 shares at $0.64 ($78K) on 2024-01-29, disclosed to the SEC on 2024-01-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.54 | 50,000 | $27K | 34.4% |
| 2 | $0.55 | 25,000 | $14K | 17.5% |
| 3 | $0.59 | 8,513 | $5K | 6.4% |
| 4 | $0.61 | 14,850 | $9K | 11.5% |
| 5 | $0.61 | 12,250 | $7K | 9.5% |
| 6 | $0.64 | 4,031 |
| $3K |
| 3.3% |
| 7 | $0.64 | 21,235 | $14K | 17.3% |
| Total | $0.58 avg | 135,879 | $78K | 100% |
| Filing → |
| CATX | BUY | 2024-11-27 | $23K | — | Filing → |
| CATX | BUY | 2024-06-03 | $76K | — | Filing → |
| CATX | BUY | 2024-05-30 | $40K | — | Filing → |